FDA NDC Directory · JSON-LD · Markdown

OLANZAPINE

NDC 55150-308 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerEugia US LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA210968
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR
Active ingredientsOLANZAPINE (10 mg/1)
Marketing started20201022
Package count2

External sources

Source: openFDA. Public-domain (CC0).